BGLC · BioNexus Gene Lab Corp
United States · RS rating 8 · As of 2026-10-14
| Price | 1.26 USD |
|---|---|
| 1-day change | -4.5% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 19 / 16 / 7 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 12 / 31 |
| Industry group (rank) | Chemicals-Specialty (73) |
| EPS growth Q/Q | -15.2% |
| Sales growth Q/Q | +12.6% |
| Distance from 52-week high | +77.0% |
| Market cap (USD) | $5.4M |